review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Kedra Wallace | Q56256861 |
Babbette LaMarca | Q88459247 | ||
P2093 | author name string | Joey Granger | |
P2860 | cites work | Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. | Q54782424 |
Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure | Q73567364 | ||
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
Pre-eclampsia | Q81446389 | ||
Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia | Q82705098 | ||
What we have learned about preeclampsia | Q28196892 | ||
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q34182166 | ||
Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia | Q35681821 | ||
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
Role of the renin-angiotensin system in the pathogenesis of preeclampsia | Q36064478 | ||
Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
Clinical aspects of parvovirus B19 infection | Q36589340 | ||
Immunoregulation in normal pregnancy and pre-eclampsia: an overview | Q36684096 | ||
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia | Q37079628 | ||
The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia | Q37088970 | ||
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. | Q43576536 | ||
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood | Q47890265 | ||
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
P433 | issue | 2 | |
P921 | main subject | pre-eclampsia | Q61335 |
autoantibody | Q785022 | ||
P304 | page(s) | 175-179 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
P1476 | title | Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia | |
P478 | volume | 11 |
Q38126570 | A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery |
Q36052778 | AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction |
Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
Q28534198 | Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A |
Q26828588 | Antibodies in the pathogenesis of hypertension |
Q36339273 | Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats |
Q36115279 | Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. |
Q34025660 | Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome |
Q36997267 | IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia |
Q36409599 | Immune Mechanisms Linking Obesity and Preeclampsia |
Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
Q55004295 | Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study. |
Q50937792 | Mechanism of agonistic angiotensin II type I receptor autoantibody-amplified contractile response to Ang II in the isolated rat thoracic aorta. |
Q38845438 | Neurological Complications of Pregnancy |
Q38017497 | Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome |
Q39423454 | Pathophysiology and Current Clinical Management of Preeclampsia |
Q35029497 | Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor |
Q92071244 | Placental CD4+ T cells isolated from preeclamptic women cause preeclampsia-like symptoms in pregnant nude-athymic rats |
Q37451544 | Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia |
Q36422506 | Placental ischemia-induced increases in brain water content and cerebrovascular permeability: role of TNF-α |
Q104137018 | Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction |
Q34494348 | Presence of autoantibody against two placental proteins, peroxiredoxin 3 and peroxiredoxin 4, in sera of recurrent pregnancy loss patients |
Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
Q39136791 | Recent Advances in Immunity and Hypertension |
Q35707881 | Receptor-activating autoantibodies and disease: preeclampsia and beyond |
Q88493279 | Regulators of G protein signaling in cardiovascular function during pregnancy |
Q41653771 | Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat. |
Q47889401 | The Complement System and Preeclampsia |
Q46238640 | The immunology of hypertension. |
Q36979856 | The renin-angiotensin system in 2011: new avenues for translational research |
Q33834419 | The role of inflammation in the pathology of preeclampsia |
Q38116097 | Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. |
Q28391593 | Vascular Tissue Contractility Changes Following Late Gestational Exposure to Multi-Walled Carbon Nanotubes or their Dispersing Vehicle in Sprague Dawley Rats |
Search more.